This study used high- and low-dose groups to explore the regulatory effect of BBR on the Nrf2-NLRP3-Caspase-1-GSDMD signalling pathway to clarify the molecular mechanism by which BBR improves the renal function of DN. The gene discussed is NLRP3; the disease is liver dysplastic nodule.